Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-14
2006-02-14
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S141000
Reexamination Certificate
active
06998408
ABSTRACT:
The present application describes 6–5, 6—6, or 6–7 heterobicycles of Formula I or pharmaceutically acceptable salt forms thereof:wherein ring P is a 6-membered heteroaromatic and ring M is a 5-, 6-, or 7-membered non-aromatic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
REFERENCES:
patent: 3340269 (1967-09-01), Blatter
patent: 3365459 (1968-01-01), Blatter
patent: 3423414 (1969-01-01), Blatter
patent: 5252584 (1993-10-01), Carling et al.
patent: WO 9420460 (1994-09-01), None
patent: WO 9612720 (1996-05-01), None
patent: WO 9852948 (1998-11-01), None
patent: WO 9900121 (1999-01-01), None
patent: WO 9900126 (1999-01-01), None
patent: WO 9900127 (1999-01-01), None
patent: WO 9900128 (1999-01-01), None
patent: WO 9932477 (1999-07-01), None
patent: WO 9950257 (1999-10-01), None
patent: WO 0119798 (2001-03-01), None
Bristol-Myers Squibb Pharma Company
Kifle Bruck
Sun Jing G.
Vance David H.
LandOfFree
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687587